HLS
$4.31
1.891%

HLS Therapeutics Inc.
Key Data

Last updated: Apr 28, 2025, 12:51 PM ET

Price Metrics  

  • Open
    4.23
  • Close
    —
  • Prev. Close
    4.23
  • Day High/Low
    4.44/4.23
  • 52 Week High/Low
    4.98/3.00
  • Alpha
    -0.024
  • Beta
    1.021
  • VWAP
    4.367

Moving Averages  

  • 21 Day Moving Average
    4.305
  • 50 Day Moving Average
    4.246
  • 200 Day Moving Average
    3.735

Valuation Metrics  

  • Market Cap (All Classes)
    137,028,033.00
  • Market Cap
    137,028,033.00
  • EPS (TTM)
    —
  • P/E Ratio (TTM)
    —
  • P/B Ratio
    1.36
  • P/CF Ratio
    7.60
  • D/E Ratio
    —
  • Return on Equity
    -23.26%
  • Return on Assets
    -10.65%

Share Statistics  

  • Total Shares (All Classes)
    31,793,047.00
  • Listed Shares Outstanding
    31,793,047.00
  • Escrow Shares
    2,356,750.00
  • Volume
    3,305.00
  • Consolidated Volume
    —
  • 10 Day Avg Vol.
    16,927.00
  • 20 Day Avg Vol.
    14,766.00
  • 30 Day Avg Vol.
    12,626.00
  • 50 Day Avg Vol.
    10,187.00

Dividends  

  • Dividend
    —
  • Dividend Frequency
    —
  • Dividend Yield (Ann)
    —
  • Ex-Date
    —
  • Payable date
    —
  • Dividend Growth (3 Year)
    -100.00%
  • Dividend Growth (5 Year)
    -100.00%

Short Interest (as of Apr 28, 2025)  

  • Short Interest as % of Float
    -%
  • Short Interest Days to Cover
    -
Want more in-depth company research in real-time?
Learn more about TMX Powerstream today.